The current earnings forecast score of Lantheus Holdings Inc is 8.15, ranking 63 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 77.00, with a high of 130.00 and a low of 60.00.
Analyst Rating
Based on
13
analysts
Buy
Current Rating
107.154
Target Price
+7.15%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Lantheus Holdings Inc
LNTH
13
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Medtronic PLC
MDT
31
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Lantheus Holdings Inc's expected revenue for the next quarter?
Lantheus Holdings Inc's expected revenue is 361.54M.
What is Lantheus Holdings Inc's price target?
Analysts forecast that Lantheus Holdings Inc's price target is USD 77.00, with the highest forecast at USD 130.00 and the lowest forecast at USD 60.00.
How have Lantheus Holdings IncLNTH's recent earnings per share performed?
The market expectation was USD 1.83, while Lantheus Holdings IncLNTH's earnings per share (EPS) for the previous quarter was USD 0.83. EPS for the next quarter is expected at USD 1.29.
What is the analyst rating for Lantheus Holdings Inc?
Based on the ratings of Lantheus Holdings Inc's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.